Form 4: FibroGen CFO Juan Graham Reports Stock Transactions
SEC Form 4 Filing
Juan Graham, CFO of FibroGen, reports stock transactions including acquisitions and disposals to cover tax obligations.
Summary
- On March 6, 2024, Juan Graham, the CFO of FibroGen, disposed of 20,327 shares of common stock at a price of $1.87 to cover tax obligations.
- On the same day, he acquired 781 shares related to a PSU Milestone Grant vesting at a price of $0.
- Also on March 6, 2024, 422 shares were withheld by the issuer to cover tax obligations related to the vesting of the PSU Milestone grant.
- On March 7, 2024, Graham disposed of 1,181 shares at a price of $1.79 to cover tax obligations.
- Following these transactions, Graham beneficially owns 203,469 shares of FibroGen common stock.
Sentiment
Score: 5
Explanation: The document is a routine filing of stock transactions. The vesting of PSU Milestone Grant is a slightly positive sign, but the sales to cover tax obligations are neutral.
Positives
- The vesting of the PSU Milestone Grant indicates that FibroGen has achieved certain performance milestones.
Industry Context
Form 4 filings are standard practice for reporting insider transactions and are closely watched by investors for insights into management's perspective on the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the CFO's stock disposals, but the overall impact is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 03/06/2024 | Disposal of 20,327 shares to cover tax obligations, acquisition of 781 shares from PSU Milestone Grant, and withholding of 422 shares for tax obligations related to the PSU Milestone Grant. |
| 03/07/2024 | Disposal of 1,181 shares to cover tax obligations. |
| 03/08/2024 | Date of signature by Michael Hom, Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.